Paper42032007
miR-16-5p mediates E2-induced cell proliferation and EMT in benign prostate hyperplasia.
Kim JE and 4 others. Sci Rep, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. miR-16-5p mediates E2-induced cell proliferation and EMT in benign prostate hyperplasia. Papers, record 42032007. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42032007
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| MicroRNAs | Major topic |
| Prostatic Hyperplasia | Major topic |
| Cell Proliferation | Major topic |
| Epithelial-Mesenchymal Transition | Major topic |
| Estradiol | Major topic |
| Humans | |
| Male | |
| Cell Line | |
| Prostate | |
| Myofibroblasts | |
| Epithelial Cells | |
| Signal Transduction |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2018R1DA1B07049449 | This work was supported by Basic Science Research of the National Research Foundation of Korea (NRF) and funded by the Ministry of Science, ICT, and Future Planning Program | PubMed |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29484411 | miR-16 inhibits hyperoxia-induced cell apoptosis in human alveolar epithelial cells. | Mol Med Rep | 2018 | https://conductscience.org/library/papers/29484411 | PubMed |
| 2 | 34352396 | The G protein-coupled estrogen receptor (GPER) regulates recognition and aversively-motivated memory in male rats. | Neurobiol Learn Mem | 2021 | https://conductscience.org/library/papers/34352396 | PubMed |
| 3 | 15763388 | Benign prostatic hyperplasia: age-related tissue-remodeling. | Exp Gerontol | 2005 | https://conductscience.org/library/papers/15763388 | PubMed |
| 4 | 11173937 | Lower urinary tract symptoms, prostate volume and uroflow in norwegian community men. | Eur Urol | 2001 | https://conductscience.org/library/papers/11173937 | PubMed |
| 5 | 19196965 | A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19196965 | PubMed |
| 6 | 36344974 | Upregulation of mir-1199-5p is associated with reduced type 2 5-α reductase expression in benign prostatic hyperplasia. | BMC Urol | 2022 | https://conductscience.org/library/papers/36344974 | PubMed |
| 7 | 16415632 | Benign prostatic hyperplasia in community-dwelling elderly in Korea. | Taehan Kanho Hakhoe Chi | 2005 | https://conductscience.org/library/papers/16415632 | PubMed |
| 8 | 38420594 | YAP-mediated GPER signaling impedes proliferation and survival of prostate epithelium in benign prostatic hyperplasia. | iScience | 2024 | https://conductscience.org/library/papers/38420594 | PubMed |
| 9 | 11789554 | Quality of life of patients on the waiting list for benign prostatic hyperplasia surgery. | Qual Life Res | 2001 | https://conductscience.org/library/papers/11789554 | PubMed |
| 10 | 18166158 | HIF-1alpha controls keratinocyte proliferation by up-regulating p21(WAF1/Cip1). | Biochim Biophys Acta | 2008 | https://conductscience.org/library/papers/18166158 | PubMed |
| 11 | 1695776 | Pathology of benign prostatic hyperplasia. Insight into etiology. | Urol Clin North Am | 1990 | https://conductscience.org/library/papers/1695776 | PubMed |
| 12 | 9358223 | Changes in keratin expression during the development of benign prostatic hyperplasia. | Eur Urol | 1997 | https://conductscience.org/library/papers/9358223 | PubMed |
| 13 | 10592173 | KEGG: kyoto encyclopedia of genes and genomes. | Nucleic Acids Res | 2000 | https://conductscience.org/library/papers/10592173 | PubMed |
| 14 | 26551285 | Epithelial-mesenchymal transition in prostatic disease. | Future Oncol | 2015 | https://conductscience.org/library/papers/26551285 | PubMed |
| 15 | 28850686 | Estradiol promotes epithelial-to-mesenchymal transition in human benign prostatic epithelial cells. | Prostate | 2017 | https://conductscience.org/library/papers/28850686 | PubMed |
| 16 | 29359788 | MicroRNA expression profiles in benign prostatic hyperplasia. | Mol Med Rep | 2018 | https://conductscience.org/library/papers/29359788 | PubMed |
| 17 | 21620560 | Androgens and estrogens in benign prostatic hyperplasia: past, present and future. | Differentiation | 2011 | https://conductscience.org/library/papers/21620560 | PubMed |
| 18 | 1700403 | Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia. | Prostate | 1990 | https://conductscience.org/library/papers/1700403 | PubMed |
| 19 | 29138833 | miR-16 mimics inhibit TGF-β1-induced epithelial-to-mesenchymal transition via activation of autophagy in non-small cell lung carcinoma cells. | Oncol Rep | 2018 | https://conductscience.org/library/papers/29138833 | PubMed |
| 20 | 34022711 | Exosomes derived from miR-16-5p-overexpressing keratinocytes attenuates bleomycin-induced skin fibrosis. | Biochem Biophys Res Commun | 2021 | https://conductscience.org/library/papers/34022711 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42032007
GET https://conductscience.org/api/papers/v1/42032007/references?page=2